You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR METHOXSALEN


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for methoxsalen

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002011 ↗ The Therakos UVAR Photopheresis System in the Treatment of AIDS-Related Complex Completed Mallinckrodt N/A 1969-12-31 To determine the safety and patient tolerance of UVAR Photopheresis System (extracorporeal photopheresis) in the Treatment of AIDS-Related Complex (ARC).
NCT00004359 ↗ Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita Completed Northwestern University Phase 2 1996-02-01 OBJECTIVES: I. Evaluate immunomodulation with extracorporeal photochemotherapy (ECP) in patients with epidermolysis bullosa acquisita. II. Investigate the effect of ECP on lymphocyte activity.
NCT00004359 ↗ Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita Completed National Center for Research Resources (NCRR) Phase 2 1996-02-01 OBJECTIVES: I. Evaluate immunomodulation with extracorporeal photochemotherapy (ECP) in patients with epidermolysis bullosa acquisita. II. Investigate the effect of ECP on lymphocyte activity.
NCT00005092 ↗ Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Completed National Cancer Institute (NCI) Phase 1 1999-05-28 RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by the chemotherapy or radiation therapy used to kill tumor cells. Sometimes the transplanted cells are rejected by the body's normal tissues. Transplanting donated cells that have been treated with psoralen may prevent this from happening. PURPOSE: Phase I trial to study the effectiveness of chemotherapy, radiation therapy, and psoralen-treated donor cells in treating patients who are undergoing peripheral stem cell transplantation for hematologic cancer.
NCT00005092 ↗ Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer Completed M.D. Anderson Cancer Center Phase 1 1999-05-28 RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by the chemotherapy or radiation therapy used to kill tumor cells. Sometimes the transplanted cells are rejected by the body's normal tissues. Transplanting donated cells that have been treated with psoralen may prevent this from happening. PURPOSE: Phase I trial to study the effectiveness of chemotherapy, radiation therapy, and psoralen-treated donor cells in treating patients who are undergoing peripheral stem cell transplantation for hematologic cancer.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for methoxsalen

Condition Name

Condition Name for methoxsalen
Intervention Trials
Lymphoma 4
Graft-versus-Host Disease 3
Myelodysplastic Syndromes 2
Leukemia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for methoxsalen
Intervention Trials
Graft vs Host Disease 7
Lymphoma 4
Syndrome 3
Mycoses 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for methoxsalen

Trials by Country

Trials by Country for methoxsalen
Location Trials
United States 122
United Kingdom 8
France 7
Italy 6
Germany 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for methoxsalen
Location Trials
Texas 10
Ohio 9
Massachusetts 9
Michigan 7
Florida 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for methoxsalen

Clinical Trial Phase

Clinical Trial Phase for methoxsalen
Clinical Trial Phase Trials
Phase 4 2
Phase 3 2
Phase 2/Phase 3 1
[disabled in preview] 15
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for methoxsalen
Clinical Trial Phase Trials
Completed 12
Terminated 5
Unknown status 3
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for methoxsalen

Sponsor Name

Sponsor Name for methoxsalen
Sponsor Trials
Mallinckrodt 13
National Cancer Institute (NCI) 4
M.D. Anderson Cancer Center 4
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for methoxsalen
Sponsor Trials
Other 27
Industry 22
NIH 5
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.